As one of the world's largest generics and specialty pharmaceutical companies, Mylan's commercial footprint spans approximately 140 countries and territories. In addition, the company enjoys leading positions in many generics markets, including France, the U.K. and the U.S.
The company's pharmaceuticals businesses fall into three categories – Generics, Active Pharmaceutical Ingredients and Specialty. Its Generics business is divided further by geography – North America; Europe, the Middle East and Africa; and Asia Pacific.
Mylan's proven ability to operate a global commercial enterprise while demonstrating sensitivity to local market needs positions it well to continue prospering in the highly competitive global generics and specialty pharmaceutical industry.